Processing

Please wait...

Settings

Settings

Goto Application

1. WO2012137645 - PREVENTIVE AND/OR THERAPEUTIC AGENT FOR ALLODYNIA CAUSED BY ANTICANCER AGENT

Publication Number WO/2012/137645
Publication Date 11.10.2012
International Application No. PCT/JP2012/058148
International Filing Date 28.03.2012
IPC
A61K 38/23 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
22Hormones
23Calcitonins
A61P 25/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
A61P 29/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (NSAIDs)
CPC
A61K 38/23
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
22Hormones
23Calcitonins
A61P 1/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
04for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
A61P 25/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
Applicants
  • 旭化成ファーマ株式会社 ASAHI KASEI PHARMA CORPORATION [JP]/[JP] (AllExceptUS)
  • 石井 邦雄 ISHII Kunio [JP]/[JP] (UsOnly)
  • 中原 努 NAKAHARA Tsutomu [JP]/[JP] (UsOnly)
  • 坂本 謙司 SAKAMOTO Kenji [JP]/[JP] (UsOnly)
  • 青木 学一 AOKI Manahito [JP]/[JP] (UsOnly)
Inventors
  • 石井 邦雄 ISHII Kunio
  • 中原 努 NAKAHARA Tsutomu
  • 坂本 謙司 SAKAMOTO Kenji
  • 青木 学一 AOKI Manahito
Agents
  • 岩瀬 吉和 IWASE Yoshikazu
Priority Data
2011-08507407.04.2011JP
Publication Language Japanese (JA)
Filing Language Japanese (JA)
Designated States
Title
(EN) PREVENTIVE AND/OR THERAPEUTIC AGENT FOR ALLODYNIA CAUSED BY ANTICANCER AGENT
(FR) AGENT PRÉVENTIF ET/OU THÉRAPEUTIQUE POUR L'ALLODYNIE PROVOQUÉE PAR UN AGENT ANTI-CANCER
(JA) 抗癌剤に起因する異痛症の予防及び/又は治療剤
Abstract
(EN)
[Problem] To provide a pharmaceutical effective in the prevention and/or treatment of allodynia caused by an anticancer agent. [Solution] A preventive and/or therapeutic agent for allodynia caused by an anticancer agent, containing natural calcitonin or a calcitonin derivative as an active ingredient is provided. Further, a method for preventing and/or treating allodynia caused by an anticancer agent by administering natural calcitonin or a calcitonin derivative, and the use of natural calcitonin or a calcitonin derivative for producing a preventive and/or therapeutic agent for allodynia caused by an anticancer agent are provided.
(FR)
L'invention a pour but de proposer un produit pharmaceutique efficace dans la prévention et/ou le traitement de l'allodynie provoquée par un agent anti-cancer. A cet effet, selon l'invention, il est proposé un agent préventif et/ou thérapeutique pour l'allodynie provoquée par un agent anti-cancer, contenant de la calcitonine naturelle ou un dérivé de calcitonine comme principe actif. De plus, l'invention concerne un procédé de prévention et/ou de traitement de l'allodynie provoquée par un agent anti-cancer par administration de calcitonine naturelle ou d'un dérivé de calcitonine, et l'utilisation de calcitonine naturelle ou d'un dérivé de calcitonine pour produire un agent préventif et/ou thérapeutique pour l'allodynie provoquée par un agent anti-cancer.
(JA)
【課題】 抗癌剤に起因する異痛症の予防及び/又は治療に有効な医薬を提供すること。 【解決手段】 天然型カルシトニン又はカルシトニン誘導体を有効成分として含有する抗癌剤に起因する異痛症の予防及び/又は治療剤が提供される。また、天然型カルシトニン又はカルシトニン誘導体を投与して抗癌剤に起因する異痛症を予防及び/又は治療する方法、並びに抗癌剤に起因する異痛症の予防及び/又は治療剤を製造するための天然型カルシトニン又はカルシトニン誘導体の使用も意図される。
Also published as
Latest bibliographic data on file with the International Bureau